Nexium /01479302/


Combined with:

Enbrel

Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 71.9%
Cardiac Failure Congestive 6.3%
Osteoporosis 6.3%
Weight Loss Diet 6.3%
Diabetes Mellitus 3.1%
Multiple Allergies 3.1%
Renal Transplant 3.1%
Condition Aggravated 16.7%
Irritability 16.7%
Osteitis 16.7%
Suicide Attempt 16.7%
Transplant Failure 16.7%
Weight Increased 16.7%
Concomitant
Product Used For Unknown Indication 68.2%
Rheumatoid Arthritis 5.0%
Gastrooesophageal Reflux Disease 3.4%
Hypertension 3.0%
Hepatitis C 2.7%
Pain 2.2%
Prophylaxis 2.1%
Osteoporosis Postmenopausal 1.9%
Chronic Hepatitis C 1.3%
Osteoporosis 1.2%
Psoriatic Arthropathy 1.0%
Diabetes Mellitus 1.0%
Nausea 0.9%
Supplementation Therapy 0.9%
Cystic Fibrosis 0.9%
Psoriasis 0.9%
Back Pain 0.9%
Depression 0.8%
Anxiety 0.8%
Blood Cholesterol Increased 0.8%
Drug Ineffective 12.2%
Weight Decreased 7.4%
Rash 7.0%
Sinusitis 7.0%
Death 5.5%
Pyrexia 5.5%
Urinary Tract Infection 5.5%
Vomiting 5.5%
Therapeutic Response Decreased 5.2%
Pain In Extremity 4.8%
Injection Site Pain 4.4%
Nausea 4.4%
Rheumatoid Arthritis 4.4%
Pain 3.7%
Psoriasis 3.7%
Headache 3.0%
Pneumonia 3.0%
Wrong Technique In Drug Usage Process 3.0%
Tremor 2.6%
Injection Site Swelling 2.2%

Drug Data